共 29 条
- [23] Use of a rectal balloon during radiotherapy for localized prostate cancer : Impact on organ movements and on dose variations to target volume and rectal wall INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S377 - S377
- [24] ReIGNITE RT Boost: An International Study Testing the Feasibility, Accuracy and Reliability of Using Restriction Spectrum Imaging (RSI) MRI to Guide Radiotherapy Target Volume Delineation for Prostate Cancer Tumor Boost INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E229 - E229
- [25] Early toxicities of ultrahypofractionated stereotactic body radiotherapy for intermediate risk localized prostate cancer using cone-beam computed tomography and real-time three-dimensional transperineal ultrasound monitoring RADIATION ONCOLOGY JOURNAL, 2021, 39 (03): : 239 - 245
- [27] Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naive men INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (04) : 288 - 294
- [28] Use of different urethrogram protocols can influence the definition of planning target volume inferior margin in prostate cancer radiotherapy.: In regard to Liu et al.:: Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement (Int J Radiat Oncol Biol Phys 2004;60:470-475) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1278 - 1278
- [29] Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer ; [ Vergleich von 68 Ga-PSMA-Liganden-PET/CT und konventioneller Schnittbildgebung zur Zielvolumendefinition für die metastasengerichtete Strahlentherapie bei metachronen Lymphknotenmetastasen durch Prostatakrebs ] Strahlentherapie und Onkologie, 2019, 195 (5) : 420 - 429